Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 196 AL 210

Multi-target drugs for Alzheimer's disease

Turgutalp B, Kizil C.

Trends Pharmacol Sci. 2024 Jul;45(7):628-638. doi: 10.1016/j.tips.2024.05.005. Epub 2024 Jun 9.

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

Zeng L, Perin J, Gross AL, Shade D, Lanctôt KL, Lerner AJ, Mintzer JE, Brawman-Mintzer O, Padala PR, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Herrmann N, Rosenberg PB.

Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.

Signaling pathways in the treatment of Alzheimer's disease with acupuncture: a narrative review

Ke C, Shan S, Tan Y, Cao Y, Xie Z, Shi S, Pan J, Zhang W.

Acupunct Med. 2024 Aug;42(4):216-230. doi: 10.1177/09645284241256669. Epub 2024 Jun 10.

Predicting how many people might receive treatment with new therapies for Alzheimer's disease

Underwood BR.

J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):793. doi: 10.1136/jnnp-2024-333941.

Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials

Chen X, Walton K, Brodaty H, Chalton K.

J Alzheimers Dis. 2024;101(s1):S479-S501. doi: 10.3233/JAD-231222.

Effects of exercise on brain-derived neurotrophic factor in Alzheimer's disease models: A systematic review and meta-analysis

Zhang S, Gu B, Zhen K, Du L, Lv Y, Yu L.

Arch Gerontol Geriatr. 2024 Nov;126:105538. doi: 10.1016/j.archger.2024.105538. Epub 2024 Jun 12.

Gantenerumab for early Alzheimer's disease: a systematic review and meta-analysis

Menegaz de Almeida A, Leite M, Lopes LM, Gomes Lima P, Siegloch Barros ML, Rocha Pinheiro S, Andrade Í, Viana P, Morbach V, Marinheiro G, de Oliveira R, Pinheiro AC.

Expert Rev Neurother. 2024 Sep;24(9):929-936. doi: 10.1080/14737175.2024.2367016. Epub 2024 Jun 16.

A Comprehensive Analytical Review of Polyphenols: Evaluating Neuroprotection in Alzheimer's Disease

Vicente-Zurdo D, Gómez-Mejía E, Rosales-Conrado N, León-González ME.

Int J Mol Sci. 2024 May 28;25(11):5906. doi: 10.3390/ijms25115906.

Special Issue "Pathophysiology and Treatment of Alzheimer's Disease"

Fessel J.

Int J Mol Sci. 2024 May 30;25(11):6015. doi: 10.3390/ijms25116015.

ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies

Volloch V, Rits-Volloch S.

Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway

Narasimhan S, Holtzman DM, Apostolova LG, Cruchaga C, Masters CL, Hardy J, Villemagne VL, Bell J, Cho M, Hampel H.

Nat Neurosci. 2024 Jul;27(7):1236-1252. doi: 10.1038/s41593-024-01669-5. Epub 2024 Jun 19.

CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review

Garemilla S, Kumari R, Kumar R.

Eur J Pharmacol. 2024 Sep 5;978:176760. doi: 10.1016/j.ejphar.2024.176760. Epub 2024 Jun 18.

Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements

Shastri D, Raj V, Lee S.

Ageing Res Rev. 2024 Aug;99:102379. doi: 10.1016/j.arr.2024.102379. Epub 2024 Jun 18.

Modulation of cholesterol metabolism with Phytoremedies in Alzheimer's disease: A comprehensive review

Koppula S, Wankhede NL, Sammeta SS, Shende PV, Pawar RS, Chimthanawala N, Umare MD, Taksande BG, Upaganlawar AB, Umekar MJ, Kopalli SR, Kale MB.

Ageing Res Rev. 2024 Aug;99:102389. doi: 10.1016/j.arr.2024.102389. Epub 2024 Jun 19.

Potential therapeutic natural compounds for the treatment of Alzheimer's disease

Huang Q, Wu W, Wen Y, Lu S, Zhao C.

Phytomedicine. 2024 Sep;132:155822. doi: 10.1016/j.phymed.2024.155822. Epub 2024 Jun 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias